As of 2025-07-18, the EV/EBITDA ratio of Hubei Guangji Pharmaceutical Co Ltd (000952.SZ) is -15.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 000952.SZ's latest enterprise value is 3,343.33 mil CNY. 000952.SZ's TTM EBITDA according to its financial statements is -218.72 mil CNY. Dividing these 2 quantities gives us the above 000952.SZ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 31.5x | 24.0x |
| Forward P/E multiples | 10.3x - 16.4x | 12.7x |
| Fair Price | (15.90) - (1.66) | (9.83) |
| Upside | -334.6% - -124.5% | -245.0% |
| Date | EV/EBITDA |
| 2025-06-25 | -14.26 |
| 2025-06-24 | -14.36 |
| 2025-06-23 | -14.01 |
| 2025-06-20 | -13.70 |
| 2025-06-19 | -13.73 |
| 2025-06-18 | -14.01 |
| 2025-06-17 | -14.17 |
| 2025-06-16 | -14.25 |
| 2025-06-13 | -14.26 |
| 2025-06-12 | -14.44 |
| 2025-06-11 | -14.49 |
| 2025-06-10 | -14.50 |
| 2025-06-09 | -14.50 |
| 2025-06-06 | -14.34 |
| 2025-06-05 | -14.18 |
| 2025-06-04 | -14.41 |
| 2025-06-03 | -14.44 |
| 2025-05-30 | -14.17 |
| 2025-05-29 | -14.25 |
| 2025-05-28 | -13.96 |
| 2025-05-27 | -14.12 |
| 2025-05-26 | -13.93 |
| 2025-05-23 | -13.94 |
| 2025-05-22 | -13.93 |
| 2025-05-21 | -14.07 |
| 2025-05-20 | -14.17 |
| 2025-05-19 | -14.04 |
| 2025-05-16 | -13.93 |
| 2025-05-15 | -13.78 |
| 2025-05-14 | -13.64 |
| 2025-05-13 | -13.69 |
| 2025-05-12 | -13.64 |
| 2025-05-09 | -13.59 |
| 2025-05-08 | -13.59 |
| 2025-05-07 | -13.51 |
| 2025-05-06 | -13.40 |
| 2025-04-30 | -13.22 |
| 2025-04-29 | -13.03 |
| 2025-04-28 | -12.84 |
| 2025-04-25 | -12.89 |
| 2025-04-24 | -12.97 |
| 2025-04-23 | -12.95 |
| 2025-04-22 | -12.93 |
| 2025-04-21 | -12.85 |
| 2025-04-18 | -12.76 |
| 2025-04-17 | -12.76 |
| 2025-04-16 | -12.69 |
| 2025-04-15 | -12.92 |
| 2025-04-14 | -12.82 |
| 2025-04-11 | -12.63 |